Brain, Vol. 125, No. 9, 1972-1979,
September 2002
© 2002 Guarantors of Brain
Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?
1 Biologie des Interactions Neurones/Glie, INSERM U495, UPMC, 2 Laboratoire de Neuropathologie, Hôpital de la Salpêtrière, IFR des Neurosciences, Paris, 3 UMR 6545, IBDM, Marseille, France and 4 Division of Neuroscience, Imperial College School of Medicine, London, UK
Correspondence to: Professor Catherine Lubetzki, INSERM U495, Hôpital de la Salpêtrière, 75651 Paris cedex 13, France E-mail: catherine.lubetzki{at}psl.ap-hop-paris.fr
Multiple sclerosis is affecting 
1 out of every 1000 individuals in the western world. After axons are denuded of myelin in the early stages of the disease, remyelination occurs, but eventually this process fails, and permanent disability is the result. During development, the polysialylated form of the neural cell adhesion molecule NCAM, PSA-NCAM, is expressed at the axonal surface and acts as a negative regulator of myelination, presumably by preventing myelin-forming cells from attaching to the axon. Removal of PSA-NCAM from the axonal surface is a prerequisite for the initiation of myelination. We questioned whether, in multiple sclerosis, re-expression of PSA-NCAM by axons could occur, and therefore account for the failure of remyelination. Forty multiple sclerosis lesions from 24 different post-mortem multiple sclerosis cases were selected by histological methods and analysed by immunohistochemistry. Demyelinated lesions and partially remyelinated lesions (shadow plaques) were studied. Controls consisted of post-mortem brain tissue from patients with amyotrophic lateral sclerosis and without neurological disease. We showed that PSA-NCAM, normally absent from adult brain, is re-expressed on demyelinated axons in the plaques. Within shadow plaques, remyelinated axons do not express PSA-NCAM. Re-expression of PSA-NCAM could act as an inhibitor of remyelination and participate in disease progression in multiple sclerosis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Dubois-Dalcq, A. Williams, C. Stadelmann, B. Stankoff, B. Zalc, and C. Lubetzki From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases Brain, July 1, 2008; 131(7): 1686 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kuhlmann, V. Miron, Q. Cuo, C. Wegner, J. Antel, and W. Bruck Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis Brain, July 1, 2008; 131(7): 1749 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Williams, G. Piaton, M.-S. Aigrot, A. Belhadi, M. Theaudin, F. Petermann, J.-L. Thomas, B. Zalc, and C. Lubetzki Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain, October 1, 2007; 130(10): 2554 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Herrero-Herranz, L. A. Pardo, G. Bunt, R. Gold, W. Stuhmer, and R. A. Linker Re-Expression of a Developmentally Restricted Potassium Channel in Autoimmune Demyelination: Kv1.4 Is Implicated in Oligodendroglial Proliferation Am. J. Pathol., August 1, 2007; 171(2): 589 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Fewou, H. Ramakrishnan, H. Bussow, V. Gieselmann, and M. Eckhardt Down-regulation of Polysialic Acid Is Required for Efficient Myelin Formation J. Biol. Chem., June 1, 2007; 282(22): 16700 - 16711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Nait-Oumesmar, N. Picard-Riera, C. Kerninon, L. Decker, D. Seilhean, G. U. Hoglinger, E. C. Hirsch, R. Reynolds, and A. Baron-Van Evercooren Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors PNAS, March 13, 2007; 104(11): 4694 - 4699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Geraerts, O. Krylyshkina, Z. Debyser, and V. Baekelandt Concise Review: Therapeutic Strategies for Parkinson Disease Based on the Modulation of Adult Neurogenesis Stem Cells, February 1, 2007; 25(2): 263 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Patrikios, C. Stadelmann, A. Kutzelnigg, H. Rauschka, M. Schmidbauer, H. Laursen, P. S. Sorensen, W. Bruck, C. Lucchinetti, and H. Lassmann Remyelination is extensive in a subset of multiple sclerosis patients Brain, December 1, 2006; 129(12): 3165 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stankoff, Y. Wang, M. Bottlaender, M.-S. Aigrot, F. Dolle, C. Wu, D. Feinstein, G.-F. Huang, F. Semah, C. A. Mathis, et al. Imaging of CNS myelin by positron-emission tomography PNAS, June 13, 2006; 103(24): 9304 - 9309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Penderis, S. A. Shields, and R. J. M. Franklin Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system Brain, June 1, 2003; 126(6): 1382 - 1391. [Abstract] [Full Text] [PDF]
|
|